Difference in biological effects between insulin-like growth factor binding protein 1 and 3

Area of Science:

• Cell Biology
• Endocrinology
• Molecular Biology

Background:

• Insulin-like growth factor binding proteins (IGFBPs) modulate insulin-like growth factor (IGF) bioactivity.
• Previous studies indicated differential functions between IGFBP-1 and IGFBP-3 in regulating DNA synthesis.

Purpose of the Study:

• To investigate and compare the distinct biological functions of IGFBP-1 and IGFBP-3.
• To elucidate the differential inhibitory effects of IGFBP-1 and IGFBP-3 on growth factor-stimulated DNA synthesis in chick embryo fibroblasts (CEFs).

Main Methods:

• Utilized recombinant human and rat IGFBP-3, and human IGFBP-1.
• Assessed the inhibition of DNA synthesis stimulated by calf serum, human serum, IGF-depleted serum growth factor (SGF) fraction, fibroblast growth factor (FGF), and transforming growth factor beta (TGF-β) in CEFs.
• Compared the dose-dependent effects and additivity of IGFBP-1 and IGFBP-3.

Main Results:

• IGFBP-3 completely inhibited serum-stimulated DNA synthesis, whereas IGFBP-1 achieved only 60% maximal inhibition.
• IGFBP-3 showed significantly greater inhibition (p < 0.001) of IGF-depleted SGF-stimulated DNA synthesis (67.1%) compared to IGFBP-1 (29.3%-34.2%).
• IGFBP-3 exhibited stronger inhibition of TGF-β-stimulated DNA synthesis (90%) than IGFBP-1 (60%), while both IGFBPs similarly inhibited FGF-stimulated DNA synthesis.

Conclusions:

• IGFBP-3 possesses distinct and more potent inhibitory functions on DNA synthesis compared to IGFBP-1, especially in the absence of IGFs.
• The differential effects suggest unique biological roles for IGFBP-1 and IGFBP-3 beyond simple IGF bioactivity regulation.
• IGFBP-3 may play a more dominant role in growth inhibition at higher concentrations, potentially replacing IGFBP-1.